BiotechTubeBiotechTube
Home/Immix Biopharma/Michael Grabow
MG

Michael Grabow

Chief Commercial Officer

Immix Biopharma

Therapeutic Areas

OncologyHematologyAutoimmune DiseasesRare Diseases

Immix Biopharma Pipeline

DrugIndicationPhase
NXC-201 (formerly HBI0101)Relapsed/Refractory AL AmyloidosisPhase 2
NXC-201Undisclosed Other Serious Diseases (Autoimmune/Immune-mediated)Phase 1 / Phase 2
Undisclosed Cell TherapyUndisclosedPre-clinical

Leadership Team at Immix Biopharma

IR
Ilya Rachman
Chief Executive Officer
GM
Gabriel Morris
Chief Financial Officer
DB
Denise Bruns
Senior Clinical Development & Regulatory Advisor
View full Immix Biopharma profile